Nils Winkelmann

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region

The molecular hallmarks of epigenetic control

From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling

Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications

Preleukemia

PRC2 mediated H3K27 methylations in cellular identity and cancer

Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

The molecular landscape of head and neck cancer

Clinical and genetic predictors of prognosis in myelodysplastic syndromes

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms

Acute Myeloid Leukemia

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia

Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia

Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes

Diagnosing and Managing Advanced Chronic Myeloid Leukemia

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression